Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes

被引:177
作者
Loo, LWM
Grove, DI
Williams, EM
Neal, CL
Cousens, LA
Schubert, EL
Holcomb, IN
Massa, HF
Glogovac, J
Li, CI
Malone, KE
Daling, JR
Delrow, JJ
Trask, BJ
Hsu, L
Porter, PL
机构
[1] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA
[3] Fred Hutchinson Canc Res Ctr, Genom Shared Resource, Seattle, WA 98109 USA
关键词
D O I
10.1158/0008-5472.CAN-04-1992
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, we performed high-resolution array comparative genomic hybridization with an array of 4153 bacterial artificial chromosome clones to assess copy number changes in 44 archival breast cancers. The tumors were flow sorted to exclude non-tumor DNA and increase our ability to detect gene copy number changes. In these tumors, losses were more frequent than gains, and gains in 1q and loss in 16q were the most frequent alterations. We compared gene copy number changes in the tumors based on histologic subtype and estrogen receptor (ER) status, i.e., ER-negative infiltrating ductal carcinoma, ER-positive infiltrating ductal carcinoma, and ER-positive infiltrating lobular carcinoma. We observed a consistent association between loss in regions of 5q and ER-negative infiltrating ductal carcinoma, as well as more frequent loss in 4p16, 8p23, 8p21, 10q25, and 17p11.2 in ER-negative infiltrating ductal carcinoma compared with ER-positive infiltrating ductal carcinoma (adjusted P values less than or equal to 0.05). We also observed high-level amplifications in ER-negative infiltrating ductal carcinoma in regions of 8q24 and 17q12 encompassing the c-myc and c-erbB-2 genes and apparent homozygous deletions in 3p21, 5q33, 8p23, 8p21, 9q34, 16q24, and 19q13. ER-positive infiltrating ductal carcinoma showed a higher frequency of gain in 16p13 and loss in l6q21 than ER-negative infiltrating ductal carcinoma. Correlation analysis highlighted regions of change commonly seen together in ER-negative infiltrating ductal carcinoma. ER-positive infiltrating lobular carcinoma differed from ER-positive infiltrating ductal carcinoma in the frequency of gain in 1q and loss in 11q and showed high-level amplifications in 1q32, 8p23, 11q13, and 11q14. These results indicate that array comparative genomic hybridization can identify significant differences in the genomic alterations between subtypes of breast cancer.
引用
收藏
页码:8541 / 8549
页数:9
相关论文
共 55 条
[1]   Profiling breast cancer by array CGH [J].
Albertson, DG .
BREAST CANCER RESEARCH AND TREATMENT, 2003, 78 (03) :289-298
[2]   Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database [J].
Anderson, WF ;
Chatterjee, N ;
Ershler, WB ;
Brawley, OW .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 (01) :27-36
[3]  
[Anonymous], 1993, Resampling-based multiple testing: Examples and methods for P-value adjustment
[4]   The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression [J].
Berx, G ;
Van Roy, F .
BREAST CANCER RESEARCH, 2001, 3 (05) :289-293
[5]  
Buerger H, 1999, J PATHOL, V187, P396, DOI 10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO
[6]  
2-L
[7]   Integration of cytogenetic landmarks into the draft sequence of the human genome [J].
Cheung, VG ;
Nowak, N ;
Jang, W ;
Kirsch, IR ;
Zhao, S ;
Chen, XN ;
Furey, TS ;
Kim, UJ ;
Kuo, WL ;
Olivier, M ;
Conroy, J ;
Kasprzyk, A ;
Massa, H ;
Yonescu, R ;
Sait, S ;
Thoreen, C ;
Snijders, A ;
Lemyre, E ;
Bailey, JA ;
Bruzel, A ;
Burrill, WD ;
Clegg, SM ;
Collins, S ;
Dhami, P ;
Friedman, C ;
Han, CS ;
Herrick, S ;
Lee, J ;
Ligon, AH ;
Lowry, S ;
Morley, M ;
Narasimhan, S ;
Osoegawa, K ;
Peng, Z ;
Plajzer-Frick, I ;
Quade, BJ ;
Scott, D ;
Sirotkin, K ;
Thorpe, AA ;
Gray, JW ;
Hudson, J ;
Pinkel, D ;
Ried, T ;
Rowen, L ;
Shen-Ong, GL ;
Strausberg, RL ;
Birney, E ;
Callen, DF ;
Cheng, JF ;
Cox, DR .
NATURE, 2001, 409 (6822) :953-958
[8]   DNA copy number changes detected by comparative genomic hybridization and their association with clinicopathologic parameters in breast tumors [J].
Cingoz, S ;
Altungoz, O ;
Canda, T ;
Saydam, S ;
Aksakoglu, G ;
Sakizli, M .
CANCER GENETICS AND CYTOGENETICS, 2003, 145 (02) :108-114
[9]  
CLARK G, 2000, DIS BREAST, V2, P489
[10]  
Courjal F, 1997, CANCER RES, V57, P4368